Europe Dietary Supplements Market By Product (Tablets & Capsules, Powder System, Liquids, Soft Gels), Ingredients (Vitamins & Minerals, Botanicals, Amino Acids, Enzymes & Others), End User (Adults, Children, Infants & Old Aged, Pregnant Woman)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Europe Dietary Supplements Market would witness market growth of 9.6% CAGR during the forecast period (2017 - 2023). Vitamin based supplements are available in multiple forms, depending on the age, sex, or by specific nutritional requirements. Amino acids, omega 3 and vitamin supplements are promoted in the form of liquids too. The healthcare manufacturers such as GSK and Pfizer have been working on promoting dietary supplements in the form of fluids to their consumer base. Botanical derived dietary forms would be the most popular and fastest growing segments, as there are concerns over the side-effects associated with the consumption of synthetic supplements. Additionally, Ayurveda is gaining prominence within the supplements sectors, as these products are considered to have zero-side effect; therefore, new markets for botanicals would eventually bloom.
Based on Product, the Dietary Supplements market segments the market into TABLEts & Capsules, Powder, Liquids, Soft Gels, and Others. Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others. Based on End User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman. Based on Regions, the Dietary Supplements market segments the market into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the Europe Dietary Supplements Market. Key companies profiled in the report include Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.